Active Implants concludes clinical trials for ‘artificial meniscus’: 4 insights

Surface Technology

The final patient was treated in clinical trials for Active Implants' NUsurface Meniscus Implant.

Here are four things to know:

1. The implant is composed of a medical grade polymer and does not require fixation to bone or soft tissues. It is designed to mimic the function of the natural meniscus and redistribute loads transmitted across the knee joint.

2. The trials are designed to evaluate the NUsurface Meniscus Implant as a treatment for persistent knee pain caused by injured or deteriorated meniscus tissue.

3. The trials enrolled a combined 243 patients, 176 of which received the NUsurface Meniscus Implant. 

4. The trials were conducted in support of Active Implants receiving FDA De Novo 510(k) clearance for the implant. 

More articles on surface technology:

16 developments in 3D-printed orthopedic and spine devices in 2018 so far

Cutting Edge Spine receives FDA clearance for PEEK-enhanced cervical interbody system: 4 insights

Titan Spine appoints new COO

Copyright © 2023 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Podcast

Featured Whitepapers